Tower Research Capital LLC (TRC) - ATOSSA THERAPEUTICS INC ownership

ATOSSA THERAPEUTICS INC's ticker is ATOS and the CUSIP is 04962H506. A total of 20 filers reported holding ATOSSA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ATOSSA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$9,753
-53.9%
13,233
-21.2%
0.00%
-100.0%
Q2 2023$21,148
+264250.0%
16,784
+61.4%
0.00%
Q1 2023$8
+300.0%
10,400
+196.2%
0.00%
Q4 2022$23,511
+8065.1%
0.00%
Q3 2022$0
-100.0%
43
-96.8%
0.00%
Q2 2022$1,000
-96.9%
1,351
-94.7%
0.00%
Q1 2022$32,000
-11.1%
25,391
+13.6%
0.00%
-100.0%
Q4 2021$36,000
+50.0%
22,360
+195.6%
0.00%0.0%
Q3 2021$24,000
-20.0%
7,564
+58.0%
0.00%0.0%
Q2 2021$30,000
+900.0%
4,787
+292.4%
0.00%
Q3 2020$3,000
-50.0%
1,220
-27.2%
0.00%
Q2 2020$6,0000.0%1,676
-25.5%
0.00%
Q2 2019$6,0002,2500.00%
Other shareholders
ATOSSA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 524,805$572,0000.39%
Laurion Capital Management LP 2,225,800$2,426,0000.04%
Ergoteles LLC 514,600$561,0000.02%
Pinz Capital Management, LP 17,900$20,0000.01%
Alpine Global Management, LLC 37,089$40,0000.01%
Game Plan Financial Advisors, LLC 10,000$11,0000.01%
Spire Wealth Management 100,300$109,0000.00%
Renaissance Technologies 1,989,995$2,169,0000.00%
D. E. Shaw & Co., Inc. 2,279,636$2,485,0000.00%
Y-Intercept (Hong Kong) Ltd 16,912$18,0000.00%
View complete list of ATOSSA THERAPEUTICS INC shareholders